Search alternatives:
point decrease » point increase (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a point » _ point (Expand Search), 5 point (Expand Search), _ points (Expand Search)
point decrease » point increase (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a point » _ point (Expand Search), 5 point (Expand Search), _ points (Expand Search)
-
12141
S1 Data -
Published 2023“…In the multivariate analysis, being underweight (adjust OR [aOR], 3.80, compared to normoweight; 95% CI, 1.23–11.7) and lower maximal inspiratory airway pressure (aOR per one cmH<sub>2</sub>O decrease, 1.05; 95% CI 1.00–1.09) remained significantly associated with extubation failure.…”
-
12142
Baseline characteristics of enrolled patients.
Published 2023“…In the multivariate analysis, being underweight (adjust OR [aOR], 3.80, compared to normoweight; 95% CI, 1.23–11.7) and lower maximal inspiratory airway pressure (aOR per one cmH<sub>2</sub>O decrease, 1.05; 95% CI 1.00–1.09) remained significantly associated with extubation failure.…”
-
12143
-
12144
-
12145
-
12146
Image_3_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.tif
Published 2022“…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”
-
12147
Image_1_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.tif
Published 2022“…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”
-
12148
Image_2_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.tif
Published 2022“…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”
-
12149
Table_2_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.docx
Published 2022“…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”
-
12150
Table_1_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.docx
Published 2022“…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”
-
12151
-
12152
-
12153
Accuracy test results.
Published 2025“…The runtime memory usage on the CIFAR-100 dataset is only 44.52%, a decrease of 44.56% compared to the baseline model. …”
-
12154
Experiment environment and parameter.
Published 2025“…The runtime memory usage on the CIFAR-100 dataset is only 44.52%, a decrease of 44.56% compared to the baseline model. …”
-
12155
Test results for NME and FR.
Published 2025“…The runtime memory usage on the CIFAR-100 dataset is only 44.52%, a decrease of 44.56% compared to the baseline model. …”
-
12156
DARTS algorithm process.
Published 2025“…The runtime memory usage on the CIFAR-100 dataset is only 44.52%, a decrease of 44.56% compared to the baseline model. …”
-
12157
Comparison result of memory usage.
Published 2025“…The runtime memory usage on the CIFAR-100 dataset is only 44.52%, a decrease of 44.56% compared to the baseline model. …”
-
12158
LKA model structure.
Published 2025“…The runtime memory usage on the CIFAR-100 dataset is only 44.52%, a decrease of 44.56% compared to the baseline model. …”
-
12159
Test results on different datasets.
Published 2025“…The runtime memory usage on the CIFAR-100 dataset is only 44.52%, a decrease of 44.56% compared to the baseline model. …”
-
12160
Comparison result of memory usage.
Published 2025“…The runtime memory usage on the CIFAR-100 dataset is only 44.52%, a decrease of 44.56% compared to the baseline model. …”